about
Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and FullerenesAerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performanceIsoxyl aerosols for tuberculosis treatment: preparation and characterization of particlesPoly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteinsPharmaceutical particle engineering via spray drying.Nanomedicine in pulmonary deliveryDry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agentAdvances in device and formulation technologies for pulmonary drug delivery.A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data.Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary deliveryFollowing the concentration of polymeric nanoparticles during nebulization.Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.Towards theranostic multicompartment microcapsules: in-situ diagnostics and laser-induced treatment.Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria.Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze DryingPreparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.Stabilization of proteins in solid form.Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.Design of fine particles for pulmonary drug delivery.The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability.Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer.Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspectsNovel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma.Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.The development of models for the evaluation of pulmonary drug disposition.'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications.Electrostatics in pharmaceutical aerosols for inhalation.Advances in metered dose inhaler technology: formulation developmentFormulation considerations for dry powder inhalers.Dry powder inhalers in COPD, lung inflammation and pulmonary infections.The future perspectives of natural materials for pulmonary drug delivery and lung tissue engineering.Inhalation drug delivery devices: technology update.Devices for dry powder drug delivery to the lung.
P2860
Q28386610-1DC86796-3AF3-4A60-B433-49FA891C70BBQ28394991-0307C7BC-6F6C-4059-89B8-725A8426CA9BQ28396917-2968775F-0290-4224-8127-F80D88B39809Q30371205-08D0B937-9DE3-4EAB-B2F0-2090D4709142Q30496354-4AF54A2D-E7E2-44E2-A4CD-5F00CD3E3DA9Q33572981-09C77E86-420A-48D3-9A6A-CA3C488ACDB5Q33811796-0399E03D-BF92-47E0-A87D-2945A56FEBB1Q33962567-E197BF6E-790C-47D7-9417-B1B1E25DC37FQ34133274-0598AF9A-3600-4BBE-9008-A874A8D39AD7Q34293432-EBAA73EB-425C-48FE-AF30-E8A37F935BD9Q34340755-8B58F18F-059E-4FB6-A953-B1B5232987DAQ34496228-462F7FD3-1ECD-490E-A04D-DD5F384D9953Q34577430-938A5B1F-445B-4D43-A5A6-0E9C2901E14EQ34614043-6BB369FB-4AC5-469A-906A-25A1F16188E0Q35205790-06E0F6DB-2C74-49C5-8E15-7BFD4F2C4ECAQ35607968-DF298E27-A5E7-4D2B-993A-807E5BA71308Q36087004-9168CD2D-1695-4E87-8803-0464B8595D03Q36105834-CC014507-A093-4DFF-940D-9ABE80E3A75CQ36195084-50F481BC-2575-4674-8011-20DB124684BBQ36217972-939C2E68-F415-47CE-893E-D9DB61A0D303Q36301885-5FC0D031-1289-48EE-98DA-E1CCED70A558Q36815946-48B50240-0447-470D-A481-0D13483B192DQ37126432-97A896F7-21A0-4C50-B058-3A0216620CACQ37158892-ABD6FD82-A72E-45A0-A3BE-6A8BF626987AQ37515669-AC66B1FD-F9DD-4EC2-AECF-CBBE2B32B49AQ37565681-258B8828-0DF1-4329-8DB5-F0DF7B80E51AQ37587394-865FDC2B-F4B2-4380-B808-A5652525B627Q37801284-33E9C673-65E9-4961-A6A7-5766C21D7974Q37937562-3B16693A-DA0B-4E98-8484-90A931F25626Q38033610-6D5171F6-4222-406B-8236-EB5D9C073738Q38072075-9EA38801-7DA6-4F09-A875-6FE09E36B381Q38074463-3BD71803-5A04-4C8A-9D02-B9E22473F6B7Q38112183-BFF8B71B-A687-4A3E-A3CF-51DC47370271Q38126939-EBEF6034-D0F9-4D71-B600-0A955C452879Q38180975-B1EBBE06-600E-40CD-8D98-A0D3E1E58D90Q38236695-596DB8D4-7E11-452C-9F40-A5E3D90601D9Q38267333-AF7B1FC0-C501-45D0-A811-3FA5A4ED0EB4Q38293299-77A6369B-C86E-4E22-A2D3-ADF69E87E677Q38364686-D4D0C279-961B-4A1C-A16D-8E11351094FAQ38474246-CD7EDCAF-04DD-4715-8DA7-D37528942A7C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Particle engineering for pulmonary drug delivery.
@ast
Particle engineering for pulmonary drug delivery.
@en
type
label
Particle engineering for pulmonary drug delivery.
@ast
Particle engineering for pulmonary drug delivery.
@en
prefLabel
Particle engineering for pulmonary drug delivery.
@ast
Particle engineering for pulmonary drug delivery.
@en
P2093
P1476
Particle engineering for pulmonary drug delivery.
@en
P2093
Albert H L Chow
Boris Y Shekunov
Henry H Y Tong
Pratibhash Chattopadhyay
P304
P356
10.1007/S11095-006-9174-3
P577
2007-03-01T00:00:00Z